Morepen Laboratories Limited (MOREPENLAB.BO)
INR 83.77
(-0.35%)
INR 83.77
(-0.35%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.48 Billion INR | 8.61% |
| 2022 | 2.28 Billion INR | -17.03% |
| 2021 | 2.75 Billion INR | 57.34% |
| 2020 | 1.75 Billion INR | 26.61% |
| 2019 | 1.38 Billion INR | 47.0% |
| 2018 | 942.01 Million INR | 22.52% |
| 2017 | 768.86 Million INR | 18.9% |
| 2016 | 646.64 Million INR | 53.45% |
| 2015 | 421.41 Million INR | 13.55% |
| 2014 | 371.13 Million INR | 11.45% |
| 2013 | 333 Million INR | -10.12% |
| 2012 | 370.5 Million INR | -4.16% |
| 2011 | 386.6 Million INR | 11.41% |
| 2010 | 347 Million INR | 9.52% |
| 2009 | 316.84 Million INR | 42.12% |
| 2008 | 222.93 Million INR | 16.78% |
| 2007 | 190.9 Million INR | 5.58% |
| 2006 | 180.81 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 2.48 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.3 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 2.48 Billion INR | 8.61% |
| 2022 FY | 2.28 Billion INR | -17.03% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.28 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 2.41 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 2.75 Billion INR | 57.34% |
| 2021 Q2 | 2.1 Billion INR | 0.0% |
| 2021 Q4 | 2.75 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 1.75 Billion INR | 26.61% |
| 2020 Q2 | 1.3 Billion INR | 0.0% |
| 2020 Q4 | 1.75 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q2 | 1.02 Billion INR | 0.0% |
| 2019 Q4 | 1.38 Billion INR | 0.0% |
| 2019 FY | 1.38 Billion INR | 47.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 942.01 Million INR | 0.0% |
| 2018 FY | 942.01 Million INR | 22.52% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 809.78 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 FY | 768.86 Million INR | 18.9% |
| 2017 Q4 | 768.86 Million INR | 0.0% |
| 2016 FY | 646.64 Million INR | 53.45% |
| 2015 FY | 421.41 Million INR | 13.55% |
| 2014 FY | 371.13 Million INR | 11.45% |
| 2013 FY | 333 Million INR | -10.12% |
| 2012 FY | 370.5 Million INR | -4.16% |
| 2011 FY | 386.6 Million INR | 11.41% |
| 2010 FY | 347 Million INR | 9.52% |
| 2009 FY | 316.84 Million INR | 42.12% |
| 2008 FY | 222.93 Million INR | 16.78% |
| 2007 FY | 190.9 Million INR | 5.58% |
| 2006 FY | 180.81 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 69.99% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -760.048% |
| Sigachi Industries Limited | 707.2 Million INR | -251.515% |
| Bal Pharma Limited | 878.11 Million INR | -183.1% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -2277.14% |
| Medico Remedies Limited | 163.37 Million INR | -1421.645% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1205.409% |
| Venus Remedies Limited | 1.21 Billion INR | -104.285% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -1719.164% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 64.945% |
| Shilpa Medicare Limited | 3.44 Billion INR | 27.929% |
| Aarti Drugs Limited | 4.85 Billion INR | 48.837% |
| Lupin Limited | 49.53 Billion INR | 94.982% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 97.465% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 92.777% |
| Windlas Biotech Limited | 621.89 Million INR | -299.74% |
| Suven Life Sciences Limited | 7.08 Million INR | -34987.396% |
| Eris Lifesciences Limited | 1.89 Billion INR | -31.509% |
| Valiant Laboratories Limited | 100.15 Million INR | -2382.12% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 50.53% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 30.888% |
| Ipca Laboratories Limited | 24.71 Billion INR | 89.941% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -109.877% |
| Achyut Healthcare Limited | 568 Thousand INR | -437565.845% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 97.481% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -72.589% |
| RPG Life Sciences Limited | 1.01 Billion INR | -146.133% |
| Mankind Pharma Limited | 15.53 Billion INR | 83.997% |
| Laurus Labs Limited | 18.45 Billion INR | 86.529% |
| Piramal Pharma Limited | 21.75 Billion INR | 88.575% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -1079.205% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 89.092% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 84.874% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 90.108% |
| Unichem Laboratories Limited | 7.04 Billion INR | 64.722% |
| Sequent Scientific Limited | 3.46 Billion INR | 28.2% |
| Novartis India Limited | 448.6 Million INR | -454.156% |
| Wanbury Limited | 360.23 Million INR | -590.095% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -7.525% |
| Wockhardt Limited | 6.4 Billion INR | 61.157% |
| Themis Medicare Limited | 705.74 Million INR | -252.245% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -1557.626% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 80.723% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 62.707% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 96.088% |
| Divi's Laboratories Limited | 31.84 Billion INR | 92.192% |
| NATCO Pharma Limited | 7 Billion INR | 64.512% |
| Gufic Biosciences Limited | 2 Billion INR | -23.998% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 41.485% |
| Ind-Swift Limited | 640.91 Million INR | -287.874% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -127.838% |
| FDC Limited | 3.88 Billion INR | 36.076% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -2437.608% |
| Granules India Limited | 13 Billion INR | 80.885% |
| Medicamen Biotech Limited | 593.75 Million INR | -318.684% |
| Alkem Laboratories Limited | 26.61 Billion INR | 90.658% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -9.089% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -9649.939% |
| Brooks Laboratories Limited | 96.1 Million INR | -2486.613% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -205.914% |
| Strides Pharma Science Limited | 11.26 Billion INR | 77.927% |
| Neuland Laboratories Limited | 3.5 Billion INR | 29.059% |
| Hikal Limited | 3.03 Billion INR | 18.15% |
| Indoco Remedies Limited | 3.53 Billion INR | 29.589% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 61.33% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -6133.556% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -101.063% |
| Hester Biosciences Limited | 755.81 Million INR | -228.911% |